Patanjali Responds Strongly to USFDA Report on Labeling Concerns ๐บ๐ธ
Patanjali Ayurveda, led by Baba Ramdev, has criticized the USFDA's recent report questioning its labeling practices, asserting their commitment to quality and transparency.
CNBC-TV18
17 views โข Jul 23, 2019
About this video
Baba Ramdev's Patanjali Ayurveda has slammed the US health regulator USFDA for its report raising concerns about differential labelling by Patanjali Ayurveda. In a report, USFDA had claimed that labels on two Patanjali products sold in India were found to have additional medicinal & dietary claims compared to the products manufactured for exports.
Video Information
Views
17
Duration
1:39
Published
Jul 23, 2019
Related Trending Topics
LIVE TRENDSRelated trending topics. Click any trend to explore more videos.